These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Response to Ivarie: Competitive bioreactor hens on the horizon. Etches RJ Trends Biotechnol; 2006 Mar; 24(3):101-2. PubMed ID: 16448712 [No Abstract] [Full Text] [Related]
7. Effects of genetic engineering on the pharmacokinetics of antibodies. Colcher D; Goel A; Pavlinkova G; Beresford G; Booth B; Batra SK Q J Nucl Med; 1999 Jun; 43(2):132-9. PubMed ID: 10429508 [TBL] [Abstract][Full Text] [Related]
8. Construction, function and immunogenicity of recombinant monoclonal antibodies. Brüggemann M; Williams GT; Caskey HM; Teale C; Spicer C; Surani MA; Neuberger MS Behring Inst Mitt; 1990 Dec; (87):21-4. PubMed ID: 2096817 [TBL] [Abstract][Full Text] [Related]
9. Competitive bioreactor hens on the horizon. Ivarie R Trends Biotechnol; 2006 Mar; 24(3):99-101. PubMed ID: 16445998 [TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antibodies and engineered antibodies in the management of cancer. James K Semin Cancer Biol; 1990 Jun; 1(3):243-53. PubMed ID: 2103499 [TBL] [Abstract][Full Text] [Related]
11. Structure and genetic engineering of antigens and antibodies: applications in immunoassays. Vihko P; Wagener C Ann Biol Clin (Paris); 1992; 50(8):607-11. PubMed ID: 1294018 [No Abstract] [Full Text] [Related]
12. Development of second generation JE vaccine with genetic engineering techniques. Manabe S Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):643-6. PubMed ID: 2561720 [No Abstract] [Full Text] [Related]
13. Plant biopharming of monoclonal antibodies. Ko K; Koprowski H Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408 [TBL] [Abstract][Full Text] [Related]
14. Antibody production without animals. Stadler BM Dev Biol Stand; 1999; 101():45-8. PubMed ID: 10566774 [TBL] [Abstract][Full Text] [Related]
15. Genetically engineered in vitro systems for biotransformation studies. Doehmer J; Schmalix WA; Greim H Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):513-8. PubMed ID: 7885078 [TBL] [Abstract][Full Text] [Related]
18. Antibody engineering. Winter GP Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):537-46; discussion 547. PubMed ID: 2573089 [TBL] [Abstract][Full Text] [Related]
19. [Construction, expression and characterization of a murine/human chimeric antibody with specificity for hepatitis B surface antigen]. Li Y; Shearman CW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):318-24. PubMed ID: 2151688 [TBL] [Abstract][Full Text] [Related]
20. Antibody engineering: current status and future development. Songsivilai S; Lachmann PJ Asian Pac J Allergy Immunol; 1990 Jun; 8(1):53-60. PubMed ID: 2203363 [No Abstract] [Full Text] [Related] [Next] [New Search]